TP53 and cancer: On the other hand, the lack of cytotoxic effects in normal cells without up-regulated Pol-1 transcription suggested that the rate of rRNA synthesis of the cells could account for the different sensitivity of cancer cells with functional p53 to the treatment with inhibitors of rRNA synthesis.